Reuters logo
Vaccine alliance says 300,000 doses of Merck's Ebola shot available for emergencies
May 12, 2017 / 2:29 PM / in 7 months

Vaccine alliance says 300,000 doses of Merck's Ebola shot available for emergencies

LONDON (Reuters) - The GAVI global vaccine alliance said on Friday some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak, after the World Health Organization confirmed a fatal case in Congo.

The vaccine, known as rVSV-ZEBOV, was shown to be highly protective against Ebola in clinical trials published last December.

A spokesman for the World Health Organization told Reuters on Friday that a person in the Democratic Republic of Congo had died after becoming infected with Ebola - a contagious virus that causes haemorrhagic fever.

Reporting by Kate Kelland; Editing by Hugh Lawson

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below